Renaissance Technologies (RenTech)'s IMVT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 726,800 shares of Immunovant, Inc. (IMVT) worth $28 M, representing 0.04% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in IMVT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 534,300 shares. Largest reduction occurred in Q3 2023, reducing 246,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Immunovant (IMVT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunovant (IMVT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +534,300 | Add 277.56% | 726,800 | $38.53 |
| Q1 2026 | +192,500 | New Buy | 192,500 | $24.84 |
| Q3 2025 | -241,400 | Sold Out | 0 | $0.00 |
| Q2 2025 | -154,500 | Reduce 39.03% | 241,400 | $16.00 |
| Q1 2025 | +315,000 | Add 389.37% | 395,900 | $17.09 |
| Q4 2024 | -108,100 | Reduce 57.20% | 80,900 | $24.77 |
| Q3 2024 | -199,100 | Reduce 51.30% | 189,000 | $28.51 |
| Q2 2024 | +48,400 | Add 14.25% | 388,100 | $26.40 |
| Q1 2024 | +321,400 | Add 1756.28% | 339,700 | $32.31 |
| Q4 2023 | -203,100 | Reduce 91.73% | 18,300 | $42.13 |
| Q3 2023 | -246,400 | Reduce 52.67% | 221,400 | $38.39 |
| Q2 2023 | -24,312 | Reduce 4.94% | 467,800 | $0.02 |
| Q1 2023 | +148,012 | Add 43.01% | 492,112 | $0.02 |
| Q4 2022 | -8,400 | Reduce 2.38% | 344,100 | $0.02 |
| Q3 2022 | +19,900 | Add 5.98% | 352,500 | $5.58 |
| Q2 2022 | +231,900 | Add 230.29% | 332,600 | $3.90 |
| Q1 2022 | +83,100 | Add 472.16% | 100,700 | $5.51 |
| Q4 2021 | +17,600 | New Buy | 17,600 | $8.52 |
| Q1 2021 | -5,600 | Sold Out | 0 | $0.00 |
| Q4 2020 | +5,600 | New Buy | 5,600 | $46.25 |
| Q3 2020 | -36,300 | Sold Out | 0 | $0.00 |
| Q2 2020 | +36,300 | New Buy | 36,300 | $24.35 |
Renaissance Technologies (RenTech)'s Immunovant Investment FAQs
Renaissance Technologies (RenTech) first purchased Immunovant, Inc. (IMVT) in Q2 2020, acquiring 36,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Immunovant, Inc. (IMVT) for 22 quarters since Q2 2020.
Renaissance Technologies (RenTech)'s largest addition to Immunovant, Inc. (IMVT) was in Q2 2026, adding 726,800 shares worth $28 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 726,800 shares of Immunovant, Inc. (IMVT), valued at approximately $28 M.
As of the Q2 2026 filing, Immunovant, Inc. (IMVT) represents approximately 0.04% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Immunovant, Inc. (IMVT) was 726,800 shares, as reported at the end of Q2 2026.